BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37337933)

  • 21. Thioridazine Sensitizes Esophageal Carcinoma Cell Lines to Radiotherapy-Induced Apoptosis In Vitro and In Vivo.
    Li H; Juan L; Xia L; Wang Y; Bao Y; Sun G
    Med Sci Monit; 2016 Jul; 22():2624-34. PubMed ID: 27453171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of GRP78 abrogates radioresistance in oropharyngeal carcinoma cells after EGFR inhibition by cetuximab.
    Sun C; Han C; Jiang Y; Han N; Zhang M; Li G; Qiao Q
    PLoS One; 2017; 12(12):e0188932. PubMed ID: 29232380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiosensitization of esophageal carcinoma cells by knockdown of HMGB1 expression.
    Zhang X; Yang X; Zhu S; Li Q; Zou N
    Oncol Rep; 2019 Mar; 41(3):1960-1970. PubMed ID: 30569171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nimotuzumab promotes radiosensitivity of EGFR-overexpression esophageal squamous cell carcinoma cells by upregulating IGFBP-3.
    Zhao L; He LR; Xi M; Cai MY; Shen JX; Li QQ; Liao YJ; Qian D; Feng ZZ; Zeng YX; Xie D; Liu MZ
    J Transl Med; 2012 Dec; 10():249. PubMed ID: 23232108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remarkable inhibition effects of afatinib alone or combining with paclitaxel in esophageal squamous cell carcinoma.
    Yang LY; Cheng ZJ; Liu Z; Wang D; Zhang N; Fan ZL; Cai HQ; Zhang Y; Cai Y; Xu X; Wang JH; Du GH; Hao JJ; Wang MR
    J Gastroenterol Hepatol; 2021 Sep; 36(9):2513-2522. PubMed ID: 33721913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. XRCC3 is a promising target to improve the radiotherapy effect of esophageal squamous cell carcinoma.
    Cheng J; Liu W; Zeng X; Zhang B; Guo Y; Qiu M; Jiang C; Wang H; Wu Z; Meng M; Zhuang H; Zhao L; Hao J; Cai Q; Xie D; Pang Q; Wang P; Yuan Z; Qian D
    Cancer Sci; 2015 Dec; 106(12):1678-86. PubMed ID: 26383967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small-molecule survivin inhibitor YM155 enhances radiosensitization in esophageal squamous cell carcinoma by the abrogation of G2 checkpoint and suppression of homologous recombination repair.
    Qin Q; Cheng H; Lu J; Zhan L; Zheng J; Cai J; Yang X; Xu L; Zhu H; Zhang C; Liu J; Ma J; Zhang X; Dai S; Sun X
    J Hematol Oncol; 2014 Aug; 7():62. PubMed ID: 25139395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated TAB182 enhances the radioresistance of esophageal squamous cell carcinoma through G2-M checkpoint modulation.
    Cao Y; Gao A; Li X; Min H; He C; Sun X; Ding WQ; Zhou J
    Cancer Med; 2021 May; 10(9):3101-3112. PubMed ID: 33787085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. lncTUG1/miR-144-3p affect the radiosensitivity of esophageal squamous cell carcinoma by competitively regulating c-MET.
    Wang P; Yang Z; Ye T; Shao F; Li J; Sun N; He J
    J Exp Clin Cancer Res; 2020 Jan; 39(1):7. PubMed ID: 31918742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reverse resistance to radiation in KYSE-150R esophageal carcinoma cell after epidermal growth factor receptor signal pathway inhibition by cetuximab.
    Jing Z; Gong L; Xie CY; Zhang L; Su HF; Deng X; Wu SX
    Radiother Oncol; 2009 Dec; 93(3):468-73. PubMed ID: 19744737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sunitinib modulates the radiosensitivity of esophageal squamous cell carcinoma cells in vitro.
    Ding YQ; Zhu HC; Chen XC; Sun XC; Yang X; Qin Q; Zhang H; Yang Y; Yang YH; Gao L; Luo JD; Zhou XF
    Dis Esophagus; 2016 Nov; 29(8):1144-1151. PubMed ID: 26542732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dasatinib, a multi-kinase inhibitor increased radiation sensitivity by interfering with nuclear localization of epidermal growth factor receptor and by blocking DNA repair pathways.
    Raju U; Riesterer O; Wang ZQ; Molkentine DP; Molkentine JM; Johnson FM; Glisson B; Milas L; Ang KK
    Radiother Oncol; 2012 Nov; 105(2):241-9. PubMed ID: 23010482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-4443 promotes radiation resistance of esophageal squamous cell carcinoma via targeting PTPRJ.
    Shi X; Liu X; Huang S; Hao Y; Pan S; Ke Y; Guo W; Wang Y; Ma H
    J Transl Med; 2022 Dec; 20(1):626. PubMed ID: 36578050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of propranolol on biological function of human esophageal squamous cell carcinoma cells].
    Zhuo QY; Qian H; Zhao BS; Qi B; Liu YZ
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2022 Nov; 38(6):754-759. PubMed ID: 37308430
    [No Abstract]   [Full Text] [Related]  

  • 35. STAT3 inhibitor stattic enhances radiosensitivity in esophageal squamous cell carcinoma.
    Zhang Q; Zhang C; He J; Guo Q; Hu D; Yang X; Wang J; Kang Y; She R; Wang Z; Li D; Huang G; Ma Z; Mao W; Zhou X; Xiao C; Sun X; Ma J
    Tumour Biol; 2015 Mar; 36(3):2135-42. PubMed ID: 25492480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oroxylin a could be a Promising Radiosensitizer for Esophageal Squamous Cell Carcinoma by Inducing G2/M Arrest and Activating Apoptosis.
    Tan C; Qian X; Ge Y; Yang B; Wang F; Guan Z; Cai J
    Pathol Oncol Res; 2017 Apr; 23(2):323-328. PubMed ID: 27585443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nutlin-3, an Antagonist of MDM2, Enhances the Radiosensitivity of Esophageal Squamous Cancer with Wild-Type p53.
    He T; Guo J; Song H; Zhu H; Di X; Min H; Wang Y; Chen G; Dai W; Ma J; Sun X; Ma J
    Pathol Oncol Res; 2018 Jan; 24(1):75-81. PubMed ID: 28341911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promising outcomes of definitive chemoradiation and cetuximab for patients with esophageal squamous cell carcinoma.
    Chen Y; Wu X; Bu S; He C; Wang W; Liu J; Guo W; Tan B; Wang Y; Wang J
    Cancer Sci; 2012 Nov; 103(11):1979-84. PubMed ID: 22845557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lobaplatin promotes radiosensitivity, induces apoptosis, attenuates cancer stemness and inhibits proliferation through PI3K/AKT pathway in esophageal squamous cell carcinoma.
    Pan S; Sun Y; Sui D; Yang T; Fu S; Wang J; Hui B; Xi R; He C; Zhang X
    Biomed Pharmacother; 2018 Jun; 102():567-574. PubMed ID: 29597090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RIG-I Promotes Tumorigenesis and Confers Radioresistance of Esophageal Squamous Cell Carcinoma by Regulating DUSP6.
    Li L; Lv L; Xu JC; He Q; Chang N; Cui YY; Tao ZC; Zhu T; Qian LT
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.